Literature DB >> 28256215

Mechanism and prognostic role of qR in V1 in patients with pulmonary arterial hypertension.

Marcin Waligóra1, Grzegorz Kopeć2, Kamil Jonas1, Anna Tyrka1, Agnieszka Sarnecka1, Tomasz Miszalski-Jamka3, Małgorzata Urbańczyk-Zawadzka3, Piotr Podolec1.   

Abstract

BACKGROUND: The presence of qR pattern in lead V1 of the 12-lead surface ECG has been proposed as a risk marker of death in patients with pulmonary arterial hypertension (PAH). We aimed to validate these findings in the modern era of PAH treatment and additionally to assess the relation of qR in V1 to PAH severity. We also investigated the possible mechanisms underlying this ECG sign.
METHODS: Consecutive patients with PAH excluding patients with congenital heart defect were recruited between February 2008 and January 2016. A 12-lead standard ECG was acquired and analyzed for the presence of qR in V1 and other potential prognostic patterns. Cardiac magnetic resonance and echocardiography were used for structural (masses and volumes) and functional (ejection fraction, eccentricity index) characterization of left (LV) and right (RV) ventricles. Standard markers of PAH severity were also assessed.
RESULTS: We enrolled 66 patients (19 males), aged 50.0±15.7years with idiopathic PAH (n=52) and PAH associated with connective tissue disease (n=14). qR in V1 was present in 26(39.4%) patients and was associated with worse functional capacity, hemodynamics and RV function. The main structural determinants of qR in V1 were RV to LV volume ratio (OR: 3.99; 95% CI: 1.47-10.8, p=0.007) and diastolic eccentricity index (OR: 15.0; 95% CI: 1.29-175.5, p=0.03). During observation time of 30.5±19.4months, 20 (30.3%) patient died, 13 (50%) patients with qR and 7 (17.5%) patients without qR pattern. Electrocardiographic determinants of survival were qR (HR: 3.06, 95% CI: 1.21-7.4; p=0.02) and QRS duration (HR: 1.02, 95% CI: 1.01-1.04; p=0.01).
CONCLUSIONS: Presence of qR in V1 reflects RV dilation and diastolic interventricular septum flattening. It is a sign of advanced PAH and predicts the risk of death in this population.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac resonance imaging; Electrocardiography; Prognosis; Pulmonary arterial hypertension

Mesh:

Year:  2017        PMID: 28256215     DOI: 10.1016/j.jelectrocard.2017.02.007

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  6 in total

1.  ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension.

Authors:  Marcin Waligóra; Anna Tyrka; Piotr Podolec; Grzegorz Kopeć
Journal:  Biomed Res Int       Date:  2018-04-10       Impact factor: 3.411

2.  The Relationship between Electrocardiographic Changes and Prognostic Factors in Severely Symptomatic Pulmonary Hypertension.

Authors:  Seyed Reza Seyyedi; Babak Sharif-Kashani; Makan Sadr; Mandana Chitsazan; Majid Malekmohammad; Atefeh Abedini; Fateme Monjazebi; Farah Naghashzadeh
Journal:  Tanaffos       Date:  2019-01

3.  A Novel Electrocardiography Model for the Diagnosis of Acute Pulmonary Embolism.

Authors:  Xiao-Feng Su; Na Fan; Xue-Mei Yang; Jun-Mei Song; Qiong-Hui Peng; Xin Liu
Journal:  Front Cardiovasc Med       Date:  2022-04-11

4.  Extended Precordial T Wave Inversions Are Associated with Right Ventricular Enlargement and Poor Prognosis in Pulmonary Hypertension.

Authors:  Marcin Waligóra; Matylda Gliniak; Jan Bylica; Paweł Pasieka; Patrycja Łączak; Piotr Podolec; Grzegorz Kopeć
Journal:  J Clin Med       Date:  2021-05-16       Impact factor: 4.241

5.  Improvement in the electrocardiograms associated with right ventricular hypertrophy after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.

Authors:  Takahiko Nishiyama; Seiji Takatsuki; Takashi Kawakami; Yoshinori Katsumata; Takehiro Kimura; Masaharu Kataoka; Hikaru Tsuruta; Yuji Itabashi; Mitsushige Murata; Shinsuke Yuasa; Yoshiyasu Aizawa; Keiichi Fukuda
Journal:  Int J Cardiol Heart Vasc       Date:  2018-05-25

6.  Assessment of electrocardiographic markers of acute and long-term hemodynamic improvement in patients with pulmonary hypertension.

Authors:  Michał Piłka; Szymon Darocha; Marta Banaszkiewicz; Maria Wieteska-Miłek; Małgorzata Mańczak; Rafał Mańczak; Piotr Kędzierski; Michał Florczyk; Anna Dobosiewicz; Adam Torbicki; Marcin Kurzyna
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-04-26       Impact factor: 1.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.